☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
Novo Nordisk
Novo Nordisk Reports the Acquisition of Cardior Pharmaceuticals for ~$1.11B
March 26, 2024
Novo Nordisk’s Awiqli Receives the CHMP’s Positive Opinion for the Treatment of Diabetes
March 21, 2024
Novo Nordisk to Acquire Ocedurenone from KBP Biosciences for ~$1.3B
October 17, 2023
PharmaShots Weekly Snapshots (October 03–06, 2023)
October 7, 2023
Novo Nordisk’ Rivfloza (nedosiran) Receives the US FDA’s Approval for Children Aged ≥9 Years and Adults with Primary Hyperoxaluria...
October 3, 2023
Novo Nordisk Reports the Acquisition of Embark Biotech for ~$514M
August 31, 2023
Load more...
Back to Home
Modal title
×
Modal body text goes here.